IRIDEX Corporation (IRIX): Price and Financial Metrics

IRIDEX Corporation (IRIX)

Today's Latest Price: $2.14 USD

0.04 (1.90%)

Updated Jul 10 3:20pm

Add IRIX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

IRIX Stock Summary

  • IRIX has a higher market value than just 10.79% of US stocks; more precisely, its current market capitalization is $29,506,662.
  • For IRIX, its debt to operating expenses ratio is greater than that reported by just 13.72% of US equities we're observing.
  • With a year-over-year growth in debt of -31.79%, Iridex Corp's debt growth rate surpasses merely 9.07% of about US stocks.
  • Stocks that are quantitatively similar to IRIX, based on their financial statements, market capitalization, and price volatility, are ISR, SPNE, PLPC, RFIL, and ITI.
  • Visit IRIX's SEC page to see the company's official filings. To visit the company's web site, go to
IRIX Daily Price Range
IRIX 52-Week Price Range

IRIX Stock Price Chart Technical Analysis Charts

IRIX Price/Volume Stats

Current price $2.14 52-week high $4.24
Prev. close $2.11 52-week low $1.22
Day low $2.02 Volume 1,945
Day high $2.18 Avg. volume 45,472
50-day MA $2.00 Dividend yield N/A
200-day MA $2.18 Market Cap 29.51M

IRIDEX Corporation (IRIX) Company Bio

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. The company was founded in 1989 and is based in Mountain View, California.

IRIX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

IRIX Latest Social Stream

Loading social stream, please wait...

View Full IRIX Social Stream

Latest IRIX News From Around the Web

Below are the latest news stories about Iridex Corp that investors may wish to consider to help them evaluate IRIX as an investment opportunity.

Edited Transcript of IRIX earnings conference call or presentation 11-May-20 9:00pm GMT

Q1 2020 IRIDEX Corp Earnings Call

Yahoo | June 16, 2020

Insights on the Retinal Surgery Devices Market to 2027 - Featuring Geuder, Insight Instruments & IRIDEX Among Others -

DUBLIN--(BUSINESS WIRE)--The "Retinal Surgery Devices - Global Market Trajectory & Analytics" report has been added to's offering. Amid the COVID-19 crisis and the looming economic recession, the Retinal Surgery Devices market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 6.8%. Vitrectomy Packs, one of the segments analyzed and sized in this study, is forecast to grow at over 7.

Business Wire | June 11, 2020

IRIDEX Corporation (NASDAQ:IRIX) Analysts Are Reducing Their Forecasts For This Year

Market forces rained on the parade of IRIDEX Corporation (NASDAQ:IRIX) shareholders today, when the analysts...

Yahoo | May 16, 2020

Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research | May 11, 2020

IRIDEX Announces First Quarter 2020 Financial Results

MOUNTAIN VIEW, Calif., May 11, 2020 -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 28, 2020. Commenting on the.

Yahoo | May 11, 2020

Read More 'IRIX' Stories Here

IRIX Price Returns

1-mo 3.38%
3-mo 21.94%
6-mo -38.33%
1-year -45.82%
3-year -77.16%
5-year -73.81%
YTD -4.04%
2019 -52.55%
2018 -38.32%
2017 -45.80%
2016 51.35%
2015 8.02%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8528 seconds.